Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients.

MLA

Talia, Marianna, et al. “Cancer-Associated Fibroblasts (CAFs) Gene Signatures Predict Outcomes in Breast and Prostate Tumor Patients.” Journal of Translational Medicine, vol. 22, no. 1, June 2024, p. 597. EBSCOhost, https://doi.org/10.1186/s12967-024-05413-2.

APA

Talia, M., Cesario, E., Cirillo, F., Scordamaglia, D., Di Dio, M., Zicarelli, A., Mondino, A. A., Occhiuzzi, M. A., De Francesco, E. M., Belfiore, A., Miglietta, A. M., Di Dio, M., Capalbo, C., Maggiolini, M., & Lappano, R. (2024). Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients. Journal of Translational Medicine, 22(1), 597. https://doi.org/10.1186/s12967-024-05413-2

Chicago

Talia, Marianna, Eugenio Cesario, Francesca Cirillo, Domenica Scordamaglia, Marika Di Dio, Azzurra Zicarelli, Adelina Assunta Mondino, et al. 2024. “Cancer-Associated Fibroblasts (CAFs) Gene Signatures Predict Outcomes in Breast and Prostate Tumor Patients.” Journal of Translational Medicine 22 (1): 597. doi:10.1186/s12967-024-05413-2.